Avery Shuei-He Yang, MClinPharm

School Of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Taiwan (Republic of China)

Poster(s):

• (SLA-016) Effectiveness of Antipsychotics in Patients with Schizophrenia
  Sunday, August 24, 2025

  12:15 PM - 1:15 PM ET

• (SLA-013) Evaluating Mortality Risk and Post-discharge Antipsychotic Use in Patients with Hospital-Onset Delirium
  Sunday, August 24, 2025

  12:15 PM - 1:15 PM ET

• (SLA-014) Metformin Use and Risk of Depression in Patients with Diabetes
  Sunday, August 24, 2025

  12:15 PM - 1:15 PM ET

• (A-173) Recalculating Propensity Score or Not for Subgroup Analysis in Propensity Score Matching and Inverse Probability of Treatment Weighting: A Monte Carlo Simulation Study
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-010) Risk of Acute Pancreatitis Associated with the Use of Dipeptidyl Peptidase-4 Inhibitors: Application of the Trend-in-Trend Design
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-301) Risk of Autoimmune Disease after COVID-19 vaccination: A modified Self-controlled case series study
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-279) The association between childhood asthma and frozen versus fresh embryo transfer in assisted reproductive technology: a nationwide retrospective cohort study using target trial emulation framework
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (C-232) Thrombosis and Bleeding Risk in Patients Receiving NOACs and P-gp Inducers or Inhibitors: A Case-Case-Time-Control for Drug Interactions Assessment
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (A-330) Type 1 Diabetes Mellitus in Individuals Receiving COVID-19 Messenger RNA Vaccination
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET